For the quarter ending 2026-03-31, NEO has $1,346,531K in assets. $517,771K in debts. $146,143K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 146,143 | 159,618 | 164,117 | 154,723 |
| Assets held for sale (note 3) | - | - | 2,078 | 8,956 |
| Marketable securities, at fair value | - | 0 | 0 | 8,962 |
| Accounts receivable, net | 167,424 | 159,242 | 155,296 | 153,125 |
| Inventories | 29,837 | 28,566 | 28,460 | 34,171 |
| Prepaid assets | 23,666 | 21,443 | 21,986 | 22,831 |
| Other current assets | 6,614 | 7,417 | 10,528 | 9,785 |
| Total current assets | 373,684 | 376,286 | 382,465 | 392,553 |
| Property and equipment (net of accumulated depreciation of 215,966 and 209,057, respectively) | 83,659 | 84,834 | 85,470 | 85,462 |
| Operating lease right-of-use assets | 76,703 | 78,444 | 80,150 | 82,870 |
| Cost | 464,834 | 467,418 | 464,834 | - |
| Accumulated amortization | 185,939 | 180,890 | 170,672 | - |
| Intangible assets, net | 278,895 | 286,528 | 294,162 | 301,795 |
| Goodwill | 523,995 | 524,344 | 524,344 | 524,143 |
| Other assets | 9,595 | 9,394 | 8,189 | 7,127 |
| Total non-current assets | 972,847 | 983,544 | 992,315 | 1,001,397 |
| Total assets | 1,346,531 | 1,359,830 | 1,374,780 | 1,393,950 |
| Liabilities held for sale (note 3) | - | - | 478 | 456 |
| Accounts payable | 25,898 | 23,090 | 22,611 | 27,492 |
| Accrued compensation | 40,576 | 47,580 | 51,301 | 48,557 |
| Accrued expenses and other liabilities | 12,727 | 12,003 | 17,393 | 18,479 |
| Current portion of operating lease liabilities | 4,828 | 4,776 | 4,507 | 4,052 |
| Current portion of convertible senior notes, net | - | 0 | 0 | 0 |
| Contract liabilities | 561 | 851 | 1,576 | 1,084 |
| Total current liabilities | 84,590 | 88,300 | 97,866 | 100,120 |
| Operating lease liabilities | 61,461 | 62,822 | 64,325 | 66,616 |
| Convertible senior notes, net | 342,240 | 341,858 | 341,476 | 341,095 |
| Deferred income tax liabilities, net | 17,450 | 18,219 | 20,846 | 19,976 |
| Other long-term liabilities | 12,030 | 12,069 | 11,977 | 12,103 |
| Total long-term liabilities | 433,181 | 434,968 | 438,624 | 439,790 |
| Total liabilities | 517,771 | 523,268 | 536,490 | 539,910 |
| Common stock, 0.001 par value, (250,000,000 shares authorized 129,653,642 and 128,989,152 shares issued and outstanding, respectively) | 129 | 129 | 128 | 128 |
| Additional paid-in capital | 1,279,539 | 1,270,235 | 1,262,016 | 1,250,679 |
| Accumulated other comprehensive income (loss) | 4 | 4 | 71 | 29 |
| Accumulated deficit | -450,912 | -433,806 | -423,925 | -396,796 |
| Total stockholders' equity | 828,760 | 836,562 | 838,290 | 854,040 |
| Total liabilities and stockholders equity | 1,346,531 | 1,359,830 | 1,374,780 | 1,393,950 |
NEOGENOMICS INC (NEO)
NEOGENOMICS INC (NEO)